A blog exploring pharmaceutical relationship marketing, emarketing and innovation with a focus on rare disorders.
SirenWired
The convergence of rare disease, digital communications, and pharmaceutical marketing communications

#SocPharm Tweetchat Transcript 9/14/2011

Posted by | 10:47pm on Wednesday, September 14, 2011

:
Welcome to the biopharm marketing & social media chat (#socpharm). Pls start w.intros & why you are interested in this.

:
@: thanks so much for moderating #socpharm tonight

:
@: here from Novo Nordisk for a short while this evening. #socpharm

:
I am guest moderating #socpharm tonight.

:
#socpharm @: : here, hi all!

:
We’ll assume that all tweets are your own and not that of your employer (unless you declare them) #socpharm

:
RT @: RT @: My key takeaway for #healthwebs, #hcsm, and anyone else: it’s not about you, it’s about the patient. #socpharm

:
Hi All – Chuck Strand with Siren here. #socpharm

:
I thought we’d start with getting the group’s thoughts on physician and social media #socpharm

:
a recent study showed that 65% of docs have used SM to support their practice #socpharm

:
q1. what do you think about this stat? do you think docs have begun to use SM more #socpharm

:
She’ll be great! RT @’Brien: @: thanks so much for moderating #socpharm tonight

:
I agree. Makes sense. What is buried in there is what type of SM they and use for what aspect fo their practice. #socpharm

:
Dan Sfera-Clinical Trials- #socpharm

:
i was surprised when i saw this stat as I thought docs were a little behind with social for prof purposes #socpharm

:
Online physician collaboration makes a lot of sense. But doc to patient could be a concern over potential liability. #socpharm

:
Part adoption & part generational RT @: q1. what do you think about this stat? do you think docs have begun to use SM more #socpharm

:
@: seems very high. is that health grades or is that involved SM? #socpharm

:
@: agree. have you seen anything that pts to what they’re using #socpharm

:
Q1 I was surprised these stats were so high. Here is study info: http://ow.ly/6uL6z #socpharm

:
@: agree. privacy issues plus other liabilities #socpharm

:
Surprised yet encouraged RT @’Brien: Q1 I was surprised these stats were so high. Here is study info: http://ow.ly/6uL6z #socpharm

:
@’Brien: thx Eileen. I switched computers and couldn’t grab the link! #socpharm

:
Q1 Nearly 30% of clinicians access online physician communities says study #socpharm

:
what are some physician SM efforts that are working? #socpharm

:
From my experiences w/physicians I work with, they are fine speaking in general terms but never to an individual on SM #socpharm

:
@: That’s what I’m here for! #socpharm

:
Q1. perhaps for identifying new types of KOLs #socpharm

:
can you elaborate? @ #socpharm

:
Q1: Manhattan Research suggests that MDs are generally ahead when it comes to new tech adoption. #socpharm

:
Surprising to see that physicians are so unaware of online patient communities. #socpharm

:
@: V. encouraging – 92% of physicians are interested in interacting w colleagues in online prof networks #socpharm

:
@ we are referencing your gr8 physician social media study over in the #socpharm tweetchat!

:
Q! @: yes, but I have also seen #s from MR thaat show they are behind in social for prof #socpharm

:
@: I would think they are using UpToDate, SERMO, etc.. SM can be vague as a definition thus some overstatement. #socpharm

:
jmikardos: : Behind who? The general population? #socpharm

:
I doubt a physician would EVER interact w/their own pts online in SM setting, but giving general advice to the masses may be ok #socpharm

:
Gr8 idea of identifying new KOLs via social media. Ideally, they will also then use sm to spread info, messages. #socpharm

:
q1 @: it is really discouraging. many patients go online to connect because they were not satisfied with answr frm dr #socpharm

:
@: yes #socpharm

:
@: and i think docs use SM but i don’t think they use as much for prof purposes #socpharm

:
@ I heard analogy: drs should consider giving sm medical advice like giving it over radio call in show! #socpharm

:
@: great point #socpharm

:
@ thank you, Rich! Back home after stem cell transplant & recouping. Thanks for all the support. Hi to all @ tonight’s #socpharm

:
LOL RT @’Brien: : @ I heard analogy: drs should consider giving sm med advice like giving it over radio show! #socpharm

:
@’Brien: Hi Eileen! How are you #socpharm

:
@: I think point is less whether MDs use SM as is which use SM as this are one we are looking to serve in SM. #socpharm

:
@: I think the RNs are more aware of online patient community & education resources & refer pts. #socpharm

:
How come we never ask what % of MDs use direct mail & journal ads anymore? :-) #socpharm

:
Q1 agree that having drs connect with patients over SM is problematics for many reasons #socpharm

:
#socpharm I think we’ve reached the point where SM has grown up and the regulatory authorities will start looking in this direction

:
@: Sending positive, healing thoughts your way! Get well soon, we miss your insights. #socpharm

:
@’Brien: @ right, be a generalist. They don’t get reimbursed for free advise yet could have liability. #socpharm

:
@’Brien: @ What would be the upside unless for marketing? #socpharm

:
@: agree #socpharm

:
LOL RT @: : How come we never ask what % of MDs use direct mail & journal ads anymore? :-) #socpharm

:
true! RT @: : How come we never ask what % of MDs use direct mail & journal ads anymore? :-) #socpharm

:
#socpharm @: : exactly, ultimately MD can use SM as a marketing tool not for communicating w/their existing pts

:
@: : Interesting question. Yes, marketing, increasing image & reputation #socpharm

:
hope so RT @: #socpharm I think we’ve reache point where SM has grown up & regulatory authorities will start looking in…

:
i hope cust service too RT @’Brien: : @: : Interesting question. Yes, marketing, increasing image & reputation #socpharm

:
@’Brien: @: web the RN’a are on SM is it as themselves or representing the practice? #socpharm

:
@: : I think RNs are on social media as themselves mostly. I was referencing office visits referring pts to online resources #socpharm

:
should we move on to topic @ #socpharm

:
typo! i meant topic 2 #socpharm

:
@’Brien: thank you! Time will tell if transplant was successful. Should be able to contribute more to #socpharm discussions soon

:
@: Bring it on! #socpharm

:
@’Brien: so the question becomes who’s task is the empowerment of the RN with the links or references – Pharma? #socpharm

:
@: : sounds like an opportunity for some smart entrepreneurs! ;) #socpharm

:
Q2 potential AEs and misinformation. there is alot of it in SM. #socpharm

:
@: : It’s definitely in pharma’s best interest to remember RNs do a lot of education. And don’t forget pharmacists. #socpharm

:
@: yes #socpharm

:
Q2 need to do right by patients #socpharm

:
Colleague summarized @ nurse info here re web/sm: http://ow.ly/6uLTo #socpharm

:
@’Brien: agreed, but then pharmacists will have to be online as well and may have similar issues to the MD’s #socpharm

:
agree! RT @’Brien: : @: : definitely in pharma’s best interest 2 remember RNs do a lot of edu & don’t forget pharmacists #socpharm

:
@: people forget that u need the 4 items for AE to be considered reportable. Although it does depend on co policy. #socpharm

:
@’Brien: yes. but there are many potentials without the 4. it does not seem rt to ignore (my opinion) #socpharm

:
@: Don’t know if you can answer, but does Sanofi (like many others) do online listening for pt insights? #socpharm

:
RT @: : Q2 .. YES misinformation ; Jury’s out on AEs (depends on each pharmas interpretation of criteria and risk tolerance #socpharm

:
@’Brien: yes #socpharm

:
@: Do you mean the potential to learn more? #socpharm

:
@ hi adam! #socpharm

:
yes. follow-up to get more info RT @’Brien: : @: Do you mean the potential to learn more? #socpharm

:
do you think ppl would feel intruded upon if you wanted to attempt followup? @’Brien: Do u mean the potential to learn more? #socpharm

:
can’t ignore potential AEs…much work still to be done to insure legal/reg comfort level across all of pharma (wide disparity) #socpharm

:
Q2 there is so much wrong info out there that poses a public safety issue. how can we handle? #socpharm

:
@’Brien: just asked a couple of collegues to join chat #socpharm

:
@: Interesting question that I can argue both ways. They are talking openly about the topic. #socpharm

:
@’Brien: who is talking? #socpharm patients?

:
#socpharm i think the cream will rise to the top in terms of quality content, so recognizing credible sources will be a must @:

:
@: But then I’ve seen people blast pharma for trying to contact them. So I think it depends on the person. #socpharm

:
@: : @’Brien: hi its dave #socpharm

:
@ do u mean credible forums and communities? that is where alot of this content is #socpharm

:
There is so much bad info online, that’s why it’s essential that pharma try to take part. #socpharm

:
@ Welcome to the #socpharm tweetchat Dave!

:
AMEN ! ! RT @’Brien: : There is so much bad info online, that’s why it’s essential that pharma try to take part. #socpharm

:
@’Brien: it’s tricky!! #socpharm

:
@: Yes, the patients are talking openly on social media about their meds, potential AE. #socpharm

:
RT @: AMEN ! ! RT @’Brien: : There is so much bad info online, that’s why it’s essential pharma try to take part. #socpharm

:
People say they want pharma to pay attention & then if we do & respond, some people cry invasion of space :) #socpharm

:
@: yes, as well as blog posts, comments on blog posts, etc #socpharm

:
i think Pharma just wants to do right by patients yet pharma needs to remain compliant #socpharm

:
@’Brien: i think if a pt posts something about a drug online, pharma has every right to respond #socpharm

:
@’Brien: it will be 2 challenging to customize by personality of pers. if pharma becomes aware. same process must be in place #socpharm

:
RT @’Brien: : People say they want pharma to pay attention & then if we do & respond, some people cry invasion of space :) #socpharm

:
@ how do you define quality & credibility? reach & influence? #socpharm

:
I’m I to late for #socpharm ??

:
@ No we’ve got a few minutes to go! #socpharm

:
no! we were just talking about AEs & misinfo in SM. any thoughts? RT @: I’m I to late for #socpharm ??

:
“@EileenO’Brien: : There is so much bad info online, that’s why it’s essential that pharma try to take part. #socpharm”–AMEN

:
@: its pretty tough, and I may not exactly have the answers, but there will likely be Editors/mods who can control that #socpharm

:
@: welcome! #socpharm

:
@ agree #socpharm

:
That’s where content curation comes in. Having a trusted person or organization filter the content. #socpharm

:
@’Brien: on the communities and blogs? #socpharm

:
#socpharm I think there is miss-info on-line but our biggest problem is we haven’t admitted paradigm changed and more ppl interested in(1/2)

:
@: Around a topic. Pulling in the info on communities or blogs to highlight what’s relevant/trustworthy. #socpharm

:
#socpharm (2/2) posting real info. Therefore we need to change our way (#pharmas way) of thinking. Not everything is bad

:
Thx @’Brien: for allowing me to guest moderate #socpharm. It was fun! Despite some distractions w/ with homework, showers & dinner!

:
@’Brien: #socpharm I think there’s more and more curation every day therefore every time miss-info is loosing the battle

:
Now our time is up! Big thanks to everyone for a lively #socpharm chat, especially moderator @: .Next week @ leads.

:
@: We couldn’t tell! Thanks so much for sharing your insights. I’ll post the link to the transcript on Friday. #socpharm

:
Will need 2 evolve there. RT @’Brien: : …where content curation comes in. Having trusted person/organization filter content. #socpharm

:
@: thanks for guest hosting! Another great session and discussion. #socpharm

About Eileen O'Brien

Eileen has more than 16 years of digital healthcare marketing experience. She is an opinion leader on social media and biopharma, and has been invited to speak at industry conferences and quoted in publications.

View other posts from Eileen

One Pingback/Trackback

    16 September 2011 at 11:09pm
    Tweetchat transcript from Wed is up ...
  • Eileen O'Brien
Siren Interactive
  • Siren Interactive
  • Rare Disease Relationship Marketing Experts
  • 626 West Jackson Blvd, Suite 100
  • Chicago, IL 60661
  • 312.204.6700
  • 866.502.6714 (Toll Free)
  • www.sireninteractive.com